Income Statement

Revenue

-5%

+80%

10Y

Currency: CNY

	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	3	0	0	0	1	1	3	5	8	10	11	13	22	32	42	52	53	51	50	47	47	47	47	47	48	48	0	0
Revenue	460 N/A	480 +4%	508 +6%	524 +3%	543 +4%	548 +1%	566 +3%	590 +4%	595 +1%	646 +9%	667 +3%	658 -1%	660 +0%	657 0%	694 +6%	718 +3%	748 +4%	755 +1%	774 +3%	783 +1%	787 +1%	813 +3%	841 +3%	781 -7%	752 -4%	797 +6%	848 +6%	1 109 +31%	1 391 +25%	1 539 +11%	1 599 +4%	1 598 0%	1 504 -6%	1 504 +0%	1 511 +0%	1 512 +0%	1 615 +7%	1 622 +0%	1 742 +7%	1 762 +1%	1 747 -1%	1 745 0%	1 659 -5%	1 585 -4%	1 506 -5%	1 433 -5%
Gross Profit
Cost of Revenue	(136)	(137)	(146)	(157)	(171)	(170)	(159)	(177)	(174)	(213)	(210)	(211)	(209)	(188)	(195)	(220)	(240)	(243)	(244)	(256)	(251)	(268)	(264)	(262)	(276)	(299)	(328)	(405)	(462)	(475)	(449)	(458)	(419)	(408)	(384)	(382)	(411)	(408)	(445)	(453)	(435)	(431)	(362)	(343)	(324)	(304)
Gross Profit	324 N/A	343 +6%	362 +6%	366 +1%	372 +2%	378 +2%	407 +8%	414 +2%	421 +2%	433 +3%	457 +6%	447 -2%	450 +1%	468 +4%	499 +7%	498 0%	509 +2%	512 +1%	530 +4%	527 -1%	536 +2%	545 +2%	577 +6%	519 -10%	476 -8%	498 +5%	520 +4%	704 +35%	929 +32%	1 064 +15%	1 151 +8%	1 140 -1%	1 084 -5%	1 096 +1%	1 127 +3%	1 130 +0%	1 204 +7%	1 215 +1%	1 297 +7%	1 310 +1%	1 312 +0%	1 315 +0%	1 297 -1%	1 242 -4%	1 181 -5%	1 129 -4%
Operating Income
Operating Expenses	(102)	(108)	(127)	(122)	(128)	(131)	(132)	(128)	(136)	(140)	(159)	(160)	(160)	(167)	(182)	(176)	(186)	(180)	(190)	(184)	(177)	(183)	(206)	(197)	(207)	(253)	(365)	(413)	(520)	(603)	(609)	(626)	(628)	(631)	(637)	(631)	(642)	(625)	(678)	(675)	(661)	(673)	(643)	(633)	(632)	(608)
Selling, General & Administrative	(100)	(105)	(91)	(118)	(123)	(127)	(96)	(121)	(128)	(132)	(107)	(154)	(156)	(153)	(122)	(163)	(169)	(171)	(135)	(143)	(127)	(125)	(144)	(143)	(150)	(186)	(278)	(333)	(427)	(502)	(474)	(500)	(503)	(495)	(483)	(498)	(501)	(489)	(506)	(520)	(502)	(507)	(438)	(458)	(457)	(435)
Research & Development	0	0	(26)	0	0	0	(27)	0	0	0	(43)	0	0	(11)	(54)	0	0	(13)	(55)	(48)	(64)	(66)	(61)	(69)	(72)	(77)	(68)	(88)	(100)	(111)	(105)	(133)	(136)	(145)	(122)	(142)	(147)	(142)	(145)	(170)	(175)	(182)	(167)	(189)	(186)	(187)
Depreciation & Amortization	0	0	(9)	0	0	0	(9)	0	0	0	(9)	0	0	0	(9)	0	0	0	(13)	0	0	0	(16)	0	0	0	(24)	0	0	0	(37)	0	0	0	(43)	0	0	0	(41)	0	0	0	(55)	0	0	0
Other Operating Expenses	(2)	(2)	(1)	(4)	(5)	(5)	(0)	(7)	(8)	(8)	(0)	(6)	(4)	(3)	3	(13)	(17)	4	13	6	14	8	16	15	15	10	5	8	7	10	7	7	11	9	11	9	6	6	14	14	17	17	17	15	12	13
Operating Income	221 N/A	235 +6%	235 0%	245 +4%	244 0%	247 +1%	275 +11%	285 +4%	285 0%	293 +3%	298 +2%	287 -4%	291 +2%	302 +4%	317 +5%	322 +1%	323 +0%	332 +3%	340 +2%	343 +1%	359 +5%	362 +1%	371 +3%	322 -13%	270 -16%	245 -9%	155 -37%	291 +88%	409 +40%	461 +13%	542 +18%	514 -5%	456 -11%	465 +2%	490 +5%	499 +2%	562 +13%	590 +5%	619 +5%	634 +3%	651 +3%	642 -1%	654 +2%	609 -7%	550 -10%	521 -5%
Pre-Tax Income
Interest Income Expense	1	1	3	4	4	6	7	7	14	13	13	13	10	8	7	7	4	3	8	7	9	12	7	6	1	0	(1)	(3)	0	(3)	(6)	(16)	(27)	(37)	(29)	(29)	(27)	(27)	(22)	(21)	(23)	(23)	(28)	(29)	(30)	(31)
Non-Reccuring Items	0	0	0	0	0	0	(0)	0	0	0	(0)	0	0	0	(0)	0	0	0	(0)	0	0	0	(0)	0	0	0	(1)	(2)	(3)	(1)	(0)	0	0	(2)	(8)	(2)	(3)	(3)	(2)	(4)	(3)	(3)	(4)	(3)	(2)	(2)
Gain/Loss on Disposition of Assets	0	(0)	1	0	0	0	(0)	0	0	0	1	(2)	(2)	0	(2)	0	(0)	0	(0)	0	0	(0)	0	0	0	0	(0)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	5	4	7	7	8	7	5	5	3	3	4	6	5	2	(0)	(1)	(0)	(0)	3	3	3	3	4	(1)	(2)	(2)	(16)	(10)	(9)	(9)	1	1	(1)	(1)	(4)	(6)	(6)	(5)	(0)	(2)	(2)	(2)	(1)	(1)	(2)	(2)
Pre-Tax Income	228 N/A	241 +6%	246 +2%	255 +3%	256 +0%	260 +2%	287 +10%	297 +4%	302 +2%	310 +3%	316 +2%	302 -4%	303 +0%	312 +3%	321 +3%	328 +2%	326 -1%	335 +3%	350 +5%	353 +1%	371 +5%	377 +2%	382 +1%	326 -15%	269 -17%	244 -10%	137 -44%	276 +102%	397 +44%	447 +13%	537 +20%	499 -7%	430 -14%	425 -1%	449 +6%	462 +3%	527 +14%	555 +5%	594 +7%	607 +2%	622 +3%	613 -1%	621 +1%	576 -7%	516 -10%	486 -6%
Net Income
Tax Provision	(34)	(36)	(36)	(37)	(37)	(38)	(42)	(42)	(43)	(43)	(44)	(43)	(44)	(45)	(48)	(49)	(47)	(50)	(49)	(50)	(53)	(53)	(50)	(42)	(35)	(39)	(15)	(33)	(47)	(47)	(67)	(64)	(56)	(50)	(55)	(58)	(59)	(67)	(71)	(74)	(90)	(87)	(90)	(82)	(59)	(54)
Income from Continuing Operations	194	205	211	218	218	222	245	255	260	266	272	259	260	266	273	280	279	285	301	303	318	323	332	284	234	205	122	243	350	400	470	436	374	375	394	404	467	488	522	532	532	526	531	495	457	432
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(3)	(9)	(32)	(51)	(65)	(64)	(44)	(27)	(11)	(5)	(2)	1	3	2	1	0	(1)	1	1	0	(0)
Net Income (Common)	194 N/A	205 +6%	211 +3%	218 +3%	218 +0%	222 +2%	245 +10%	255 +4%	260 +2%	266 +3%	272 +2%	259 -5%	260 +0%	266 +3%	273 +3%	281 +3%	280 0%	286 +2%	301 +5%	303 +1%	318 +5%	323 +2%	332 +3%	284 -14%	234 -18%	202 -14%	112 -44%	212 +89%	299 +41%	335 +12%	406 +21%	392 -3%	347 -11%	364 +5%	389 +7%	402 +3%	468 +16%	491 +5%	524 +7%	533 +2%	533 0%	526 -1%	533 +1%	495 -7%	457 -8%	432 -6%
EPS (Diluted)	0.48 N/A	0.51 +6%	0.42 -18%	0.43 +2%	0.87 +102%	0.44 -49%	0.98 +123%	0.51 -48%	0.52 +2%	0.54 +4%	0.55 +2%	0.52 -5%	0.53 +2%	0.54 +2%	0.54 N/A	0.57 +6%	0.56 -2%	0.57 +2%	0.57 N/A	0.6 +5%	0.63 +5%	0.64 +2%	0.66 +3%	0.57 -14%	0.47 -18%	0.37 -21%	0.21 -43%	0.37 +76%	0.52 +41%	0.57 +10%	0.69 +21%	0.67 -3%	0.59 -12%	0.62 +5%	0.67 +8%	0.69 +3%	0.81 +17%	0.84 +4%	0.88 +5%	0.92 +5%	0.92 N/A	0.91 -1%	0.9 -1%	0.83 -8%	0.77 -7%	0.72 -6%

Income Statement Balance Sheet Cash Flow Statement

Beijing Strong Biotechnologies Inc
SZSE:300406

Income Statement

Earnings Waterfall
Beijing Strong Biotechnologies Inc

Income Statement
Beijing Strong Biotechnologies Inc

See Also

Company

Help

Tools

Stocks

Beijing Strong Biotechnologies Inc SZSE:300406

Income Statement

Earnings Waterfall Beijing Strong Biotechnologies Inc

Income Statement Beijing Strong Biotechnologies Inc

See Also

Company

Help

Tools

Stocks

Beijing Strong Biotechnologies Inc
SZSE:300406

Earnings Waterfall
Beijing Strong Biotechnologies Inc

Income Statement
Beijing Strong Biotechnologies Inc